International Transporter Consortium commentary on clinically important transporter polymorphisms. Read more about International Transporter Consortium commentary on clinically important transporter polymorphisms.
CYP2A6 genotype but not age determines cotinine half-life in infants and children. Read more about CYP2A6 genotype but not age determines cotinine half-life in infants and children.
Emerging transporters of clinical importance: an update from the International Transporter Consortium. Read more about Emerging transporters of clinical importance: an update from the International Transporter Consortium.
CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion. Read more about CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.
The UCSF-FDA TransPortal: a public drug transporter database. Read more about The UCSF-FDA TransPortal: a public drug transporter database.
Highlights from the International Transporter Consortium second workshop. Read more about Highlights from the International Transporter Consortium second workshop.
The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin. Read more about The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.
Translational bioinformatics: data-driven drug discovery and development. Read more about Translational bioinformatics: data-driven drug discovery and development.
Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing. Read more about Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.
Cannabinoid-opioid interaction in chronic pain. Read more about Cannabinoid-opioid interaction in chronic pain.
